SCHEMBL19476165

SCHEMBL19476165

COc1ccccc1NC(=O)c1cc2ccccc2[nH]1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.64
RAB9A P51151 3/20 0.64
TP53 P04637 1/20 0.63
SMN1; SMN2 Q16637 2/20 0.59
LMNA P02545 1/20 0.59
FLT3 P36888 1/20 0.59
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 2/20 0.58
MAPT P10636 1/20 0.58
CCKAR P32238 1/20 0.58
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
GFER P55789 1/20 0.57
SMO Q99835 1/20 0.55
EGFR P00533 3/20 0.55
PIK3CA P42336 3/20 0.55
GAA P10253 1/20 0.55
MAPK1 P28482 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
IMPDH2 P12268 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19476159 0.87 NPC1 (0.70) NPC1RAB9ATP53SMN1; SMN2LMNA
SCHEMBL19476098 0.86 NPC1 (0.64) NPC1RAB9ASMN1; SMN2LMNAFLT3
SCHEMBL14592325 0.84 NPC1 (0.56) NPC1RAB9ASMN1; SMN2LMNAFLT3
SCHEMBL19476167 0.84 NPC1 (0.60) NPC1RAB9ASMN1; SMN2LMNAFLT3
SCHEMBL12327680 0.82 NPC1 (0.54) NPC1RAB9ASMN1; SMN2LMNAFLT3
SCHEMBL2433191 0.82 NPC1 (0.54) NPC1RAB9ATP53SMN1; SMN2LMNA
SCHEMBL19476162 0.82 NPC1 (0.64) NPC1RAB9ASMN1; SMN2LMNAFLT3
SCHEMBL27336120 0.82 RAB9A (0.73) NPC1RAB9ATP53SMN1; SMN2LMNA
SCHEMBL19476084 0.82 NPC1 (0.69) NPC1RAB9ATP53SMN1; SMN2LMNA
SCHEMBL5740825 0.81 NPC1 (0.53) NPC1RAB9ASMN1; SMN2LMNAFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10759765-B2 Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute CE PHARM CO., LTD. (CN) 2020-09-01 US disclosed
US-20190127337-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE CE PHARM CO., LTD. (CN) 2019-05-02 US disclosed
EP-3444031-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) 2019-02-20 EP disclosed
WO-2017177979-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE 中国科学院上海有机化学研究所 2017-10-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127337-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE AOC1, AOC2, AOC3 NPC1 3545/4885RAB9A 2403/4885TP53 2426/4885
US-10759765-B2 Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute AOC1, AOC2, AOC3 NPC1 3545/4885RAB9A 2403/4885TP53 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.